Skip to the content
Search
Beyond Type 2
Menu
BEYOND TYPE 2
Show sub menu
About
Our Story
Founding Partners
Board of Directors
Leadership Council
The Team
Join Us
Contact
Diabetes
Type 1 Info
Type 2 Info
Prediabetes Info
Forms of Diabetes
Newly Diagnosed
Diabetes Management
Pregnancy and Diabetes
Resources
GetInsulin.org
Insulin for T2D
Diabetes Management
Understanding T2D
Exercise
Food
Heart Health
Mental Health
Continuous Glucose Monitoring (CGM)
Veterans with Diabetes
Beyond Type 2 Advocacy
Stories
Diabetes News
Type 2 Stories
Community
Beyond Type 2 App
Marathon Team
En Español
Search
Tag:
advocacy
Drug Rebates, Insulin and Affording Life with Diabetes in the United States
The issues surrounding drug rebates in the U.S. highlight the need for reform, especially when it comes to insulin and living with diabetes.
Civica Rx Aims to Bring $30 Insulin to Market in 2024
Launching to market in 2024, Civica Rx aims to make insulin available for no more than $30 per vial, regardless of insurance status.
Healthcare Providers Will No Longer Be Allowed to Issue “Surprise” Bills
Editor’s Note: People who take insulin require consistently affordable and predictable sources of insulin at all times. If you or a loved one are struggling to afford or access insulin, you can buil...
Over Insulin Pricing, Mississippi AG Sues Insulin Manufacturers and Pharmacy Benefit Managers
MS attorney general Lynn Fitch filed a lawsuit against PBMs & insulin manufacturers for allegedly working together to inflate insulin prices.
Combating Bullying: How One Person With Diabetes Fought To Test Her Blood Sugar In The Workplace
Sheri Byrne shares her experience on how she fought workplace bullying due to diabetes and advocated for herself.
How Rebates—Most of the Cost of Your Insulin—Work
The rebate system creates up to 70% of the current list price of insulin in the US, and it doesn’t have to be this way.
Inside the Senate Report on Rising Insulin Prices
A January 2021 Senate Finance Committee report dug into the rapidly increasing cost of insulin. Here, we summarize and explain their findings.
Get the Facts on Insulin Pricing + The Presidential Transition
A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin.
New Year, New Administration: What’s Coming For US Healthcare Policy
With a new governmental administration, it is likely we will see notable and impactful movement in healthcare policy. What can we expect?
Your Vote Matters: All About State-Based Insulin Price Cap Laws
Your vote this November could impact the continued conversation on the price of insulin. Know your role as an advocate and where you stand.
Posts navigation
←
Newer
Posts
1
2
3
4
Older
Posts
→